Met-Lys-bradykinin [5113]
Met-Lys-bradykinin
| SMILES |
CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O |
| InChIKey |
SSXPFNXUSFJJEI-BHEJXMHWSA-N |
| Sequence |
MKRPPGFSPFR |
| HELM |
PEPTIDE1{M.K.R.P.P.G.F.S.P.F.R}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
17 |
| Hydrogen bond donors |
15 |
| Rotatable bonds |
38 |
| Log P |
-4.137 |
| Molecular weight (Da) |
1318.7 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.